Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-25-026256
Filing Date
2025-03-31
Accepted
2025-03-31 16:11:43
Documents
80
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0235549-10k_aditxt.htm   iXBRL 10-K 2540265
2 CONSENT OF DBBMCKENNON, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea023554901ex23-1_aditxt.htm EX-23.1 3094
3 CERTIFICATION ea023554901ex31-1_aditxt.htm EX-31.1 11699
4 CERTIFICATION ea023554901ex31-2_aditxt.htm EX-31.2 11562
5 CERTIFICATION ea023554901ex32-1_aditxt.htm EX-32.1 5920
11 GRAPHIC image_001.jpg GRAPHIC 19369
12 GRAPHIC image_004.jpg GRAPHIC 13436
  Complete submission text file 0001213900-25-026256.txt   13341445

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adtx-20241231.xsd EX-101.SCH 112461
7 XBRL CALCULATION FILE adtx-20241231_cal.xml EX-101.CAL 54172
8 XBRL DEFINITION FILE adtx-20241231_def.xml EX-101.DEF 551034
9 XBRL LABEL FILE adtx-20241231_lab.xml EX-101.LAB 997748
10 XBRL PRESENTATION FILE adtx-20241231_pre.xml EX-101.PRE 581598
82 EXTRACTED XBRL INSTANCE DOCUMENT ea0235549-10k_aditxt_htm.xml XML 1314070
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39336 | Film No.: 25793346
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)